QCM
DGX icon

QRG Capital Management’s Quest Diagnostics DGX Stock Holding History

QRG Capital Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.47M Buy
25,798
+3,447
+15% +$677K 0.05% 291
2026
Q1 		$4.38M Buy
22,351
+2,975
+15% +$578K 0.05% 298
2025
Q4 		$3.36M Buy
19,376
+419
+2% +$76.3K 0.04% 322
2025
Q3 		$3.61M Sell
18,957
-67,700
-78% -$12M 0.04% 290
2025
Q2 		$15.6M Buy
86,657
+11,008
+15% +$1.91M 0.14% 156
2025
Q1 		$12.8M Buy
75,649
+2,006
+3% +$330K 0.13% 160
2024
Q4 		$11.1M Buy
73,643
+2,012
+3% +$313K 0.11% 174
2024
Q3 		$11.1M Buy
71,631
+28,025
+64% +$4.19M 0.12% 167
2024
Q2 		$5.97M Buy
43,606
+2,148
+5% +$294K 0.07% 235
2024
Q1 		$5.52M Sell
41,458
-18,446
-31% -$2.39M 0.07% 249
2023
Q4 		$8.26M Buy
59,904
+2,492
+4% +$328K 0.12% 178
2023
Q3 		$7M Buy
+57,412
New +$7.65M 0.12% 179

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

QRG Capital Management's DGX Position: Q2 2026 in Review

QRG Capital Management increased its Quest Diagnostics (DGX) stake by 15% in Q2 2026, buying an estimated $677K and bringing the position to 25,798 shares worth $5.47M. The position accounts for 0.05% of the portfolio, ranked #291.

QRG Capital Management first reported a position in DGX in Q3 2023 and has held it in 12 quarters since. The position peaked at $15.6M in Q2 2025. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • QRG Capital Management held 25,798 shares of Quest Diagnostics worth $5.47M as of Q2 2026.
  • QRG Capital Management bought 3,447 Quest Diagnostics shares in Q2 2026, an estimated $677K.
  • Quest Diagnostics made up 0.05% of QRG Capital Management's portfolio in Q2 2026, its #291 holding.
  • QRG Capital Management first reported a position in Quest Diagnostics in Q3 2023 and has held it in 12 quarters since.
  • QRG Capital Management's Quest Diagnostics position peaked at $15.6M in Q2 2025.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on QRG Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.